Elizabeth J. Abraham ’95, Andover, Massachusetts, is director of new product strategy at Corning Life Sciences. She has more than 20 years of experience in technical, product and business leadership, resulting in the launch of more than 90 new laboratory consumables and medical device products sold globally. She received 12 U.S. patents, authored more than 30 articles in journals and scientific magazines, and is recognized as a thought leader and innovator in stem cells, 3D cell culture and medical device products.

She earned a doctorate in animal sciences and industry from K-State in 1995.

After her doctoral program, she completed two post-doctoral stints at Harvard Medical School and Medical University of South Carolina (MUSC) in the field of endocrine sciences. As a HHMI fellow at Harvard, she was instrumental in identifying stem cells within the pancreatic islets of Langerhans and subsequently licensed by a cell therapy company, where she led the pre-clinical effort on the potential use of stem cells in diabetes mellitus.

She then shifted her career focus to medical devices and laboratory consumables. Abraham has been employed at Corning Life Sciences for more than 16 years where she has held multiple senior roles in various functions including research and development, business operations, product and market management and business strategy. She led the development and global commercialization of various new products in Life Sciences including advanced matrices, surface coatings and devices for cell culture.

Elizabeth and her husband, Vijoy, have two adult daughters, Michaela and Karina.